[1
]
From the National Hospital Organization Osaka National Hospital, Osaka (N.M.), Hiroshima
City Hiroshima Citizens Hospital, Hiroshima (S. Ohtani), Kyoto Prefectural University
of Medicine (I.Y.), and Graduate School of Medicine, Kyoto University (M.T.), Kyoto,
Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital (K.K.),
and Chuo University (Y.O.), Tokyo, Gunma Prefectural Cancer Center, Ota (Y.Y.), National
Hospital Organization Kyushu Cancer Center, Fukuoka (S. Ohno), Hyogo Cancer Center,
Akashi (S.T.), National Hospital Organization Shikoku Cancer Center, Matsuyama (K.A.),
Aichi Cancer Center Hospital, Nagoya (H.I.), and Tohoku University, Sendai (H.S.)
- all in Japan; and Yeungnam University Hospital, Daegu (S.-J.L.), Samsung Medical
Center, Sungkyunkwan University School of Medicine (Y.-H.I.), Cancer Research Institute,
Seoul National University Hospital, Seoul National University College of Medicine
(S.-A.I.), Severance Hospital (B.-W.P.) and Gangnam Severance Hospital (J.J.), Yonsei
University College of Medicine, Asan Medical Center, University of Ulsan College of
Medicine (S.-B.K.), Korea University Guro Hospital (A.K.), and Korea University Anam
Hospital (K.-H.P.), Seoul, and National Cancer Center, Goyang-si (E.-S.L.) - all in
South Korea.